# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-001787
Filing Date
2025-01-10
Accepted
2025-01-10 17:18:53
Documents
64
Period of Report
2024-10-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1073090
2 |  | ex14.htm | EX-14 | 47990
3 |  | ex23-1.htm | EX-23.1 | 3738
4 |  | ex31-1.htm | EX-31.1 | 17286
5 |  | ex31-2.htm | EX-31.2 | 17331
6 |  | ex32-1.htm | EX-32.1 | 6566
7 |  | ex32-2.htm | EX-32.2 | 6575
| Complete submission text file | 0001493152-25-001787.txt |  | 5400193

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | anix-20241031.xsd | EX-101.SCH | 31630
9 | XBRL CALCULATION FILE | anix-20241031_cal.xml | EX-101.CAL | 50266
10 | XBRL DEFINITION FILE | anix-20241031_def.xml | EX-101.DEF | 166508
11 | XBRL LABEL FILE | anix-20241031_lab.xml | EX-101.LAB | 360841
12 | XBRL PRESENTATION FILE | anix-20241031_pre.xml | EX-101.PRE | 286068
67 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 710136

Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-37492 | Film No.: 25523959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)